Detection vs Diagnosis: iRhythm and the Apple Watch

Posted by iRhythm Technologies on March 14, 2019

Will the Apple Heart Study allow early detection of arrhythmias, or drive the worried well to doctors unnecessarily? For iRhythm Technologies, either is a good outcome.

Zio is entirely different from the kind of consumer engagement approach to digital health Apple is pursuing. The patch is worn on the patient’s chest for three to 14 days, during which it makes more sophisticated determinations than the Apple Watch is capable of.

“It’s a prescription-only diagnostic that provides a definitive diagnosis of all 12 classes of arrhythmia – not just AF but ventricular tachycardia, atrioventricular block, supraventricular tachycardia."

View article


Have a question?